Host: Matthew J. Sorrentino, MD, FACC, FASH

Guest: Robert S. Rosenson, MD

Will novel HDL cholesterol therapies reduce cardiovascular risk? Dr. Robert Rosenson will discuss the hope for CETP inhibitors and HDL mimetics to modify HDL cholesterol and coronary heart disease risk.